Target Values of Cardiovascular Risk Factors Are Not Associated with All-Cause Mortality in Patients with Type 2 Diabetes Mellitus

被引:2
|
作者
Pacilli, Antonio [1 ]
Lamacchia, Olga [2 ]
Fontana, Andrea [3 ]
Copetti, Massimiliano [3 ]
Cignarelli, Mauro [2 ]
Trischitta, Vincenzo [4 ,5 ]
De Cosmo, Salvatore [1 ]
机构
[1] IRCCS Casa Sollievo Sofferenza, Dept Med Sci, Unit Internal Med, San Giovanni Rotondo, Italy
[2] Univ Foggia, Dept Surg & Med Sci, Unit Endocrinol & Metab Dis, Foggia, FG, Italy
[3] IRCCS Casa Sollievo Sofferenza, Unit Biostat, San Giovanni Rotondo, Italy
[4] IRCCS Casa Sollievo Sofferenza, Res Unit Diabet & Endocrine Dis, San Giovanni Rotondo, Italy
[5] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy
来源
PLOS ONE | 2015年 / 10卷 / 04期
关键词
GLUCOSE CONTROL; BLOOD-PRESSURE; FOLLOW-UP; METAANALYSIS; CHOLESTEROL; PEOPLE; DISEASE; EVENTS; COMPLICATIONS; PREVENTION;
D O I
10.1371/journal.pone.0124536
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background To investigate prospectively the relationship between target values of glycated hemoglobin, blood pressure and LDL-cholesterol, as considered in a combined fashion, and all-cause mortality in patients with type 2 diabetes mellitus. Methods Two cohorts of patients with type 2 diabetes mellitus, the Gargano Mortality Study (n=810) and the Foggia Mortality Study (n=929), were investigated. A weighted target risk score was built as a weight linear combination of the recommended targets reached by each patient. Results In the Gargano Mortality Study and in the Foggia Mortality Study (mean follow up=7.4 and 5.5 years, respectively), 161 (19.9%) and 220 (23.7%) patients died, with an age and sex adjusted annual incidence rate of 2.1 and 2.8 per 100 person-years, respectively. In both study samples the weighted target risk score tended to be linearly associated with all-cause mortality (HR for one point increment=1.30, 95% CI: 1.11-1.53, p=0.001, and HR=1.08, 95% CI: 0.95-1.24, p=0.243, respectively). When the two cohorts were pooled and analyzed together, a clear association between weighted target risk score and all-cause mortality was observed (HR for one point increment=1.17, 95% CI: 1.05-1.30, p=0.004). This counter-intuitive association was no longer observable in a model including age, sex, body mass index, smoking habit, estimated glomerular filtration rate, albuminuria and anti-diabetic, anti-hypertensive and anti-dyslipidemic treatment as covariates (HR for one point increment=0.99, 95% CI: 0.87-1.12, p=0.852). Conclusions In a real life clinical set of patients with type 2 diabetes mellitus, the combination of recommended target values of established cardiovascular risk factors is not associated with allcause mortality.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Severe Hypoglycemia and Cardiovascular or All-Cause Mortality in Patients with Type 2 Diabetes
    Cha, Seon-Ah
    Yun, Jae-Seung
    Lim, Tae-Seok
    Hwang, Seawon
    Yim, Eun-Jung
    Song, Ki-Ho
    Yoo, Ki-Dong
    Park, Yong-Moon
    Ahn, Yu-Bae
    Ko, Seung-Hyun
    DIABETES & METABOLISM JOURNAL, 2016, 40 (03) : 202 - 210
  • [2] All-Cause and Cardiovascular Mortality following Treatment with Metformin or Glyburide in Patients with Type 2 Diabetes Mellitus
    Raee, Mohammad Reza
    Nargesi, Arash Aghajani
    Heidari, Behnam
    Mansournia, Mohammad Ali
    Larry, Mehrdad
    Rabizadeh, Soghra
    Zarifkar, Mitra
    Esteghamati, Alireza
    Nakhjavani, Manouchehr
    ARCHIVES OF IRANIAN MEDICINE, 2017, 20 (03) : 141 - 146
  • [3] Body Mass Index and Risk of All-Cause and Cardiovascular Disease Mortality in Patients With Type 2 Diabetes Mellitus
    Wu, Cui
    Li, Yuandong
    Li, Na
    Chan, Ka Kei
    Piao, Chunli
    ENDOCRINOLOGY, 2025, 166 (04)
  • [4] Cardiovascular and all-cause mortality in patients with type 2 diabetes mellitus and chronic kidney disease
    Kawada, Tomoyuki
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (03) : 646 - 646
  • [5] HbA1c and all-cause mortality risk among patients with type 2 diabetes
    Li, Weiqin
    Katzmarzyk, Peter T.
    Horswell, Ronald
    Wang, Yujie
    Johnson, Jolene
    Hu, Gang
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 202 : 490 - 496
  • [6] Response to cardiovascular and all-cause mortality in patients with type 2 diabetes mellitus and chronic kidney disease
    Angel Salinero-Fort, Miguel
    San Andres-Rebollo, Javier
    Gomez-Campelo, Paloma
    Lopez de Andres, Ana
    Jimenez-Garcia, Rodrigo
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (03) : 647 - 647
  • [7] All-cause mortality and factors associated with it in finnish patients with type 1 diabetes
    Putula, Elena
    Kauppala, Tuuli
    Vanhamaki, Sini
    Haapakoski, Jaason
    Laatikainen, Tiina
    Metso, Saara
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2024, 38 (12)
  • [8] Body Mass Index and the Risk of All-Cause Mortality Among Patients With Type 2 Diabetes Mellitus
    Zhao, Wenhui
    Katzmarzyk, Peter T.
    Horswell, Ronald
    Wang, Yujie
    Li, Weiqin
    Johnson, Jolene
    Heymsfield, Steven B.
    Cefalu, William T.
    Ryan, Donna H.
    Hu, Gang
    CIRCULATION, 2014, 130 (24) : 2143 - +
  • [9] Aspirin Is Associated With Reduced Cardiovascular and All-Cause Mortality in Type 2 Diabetes in a Primary Prevention Setting - The Fremantle Diabetes Study
    Ong, Greg
    Davis, Timothy M. E.
    Davis, Wendy A.
    DIABETES CARE, 2010, 33 (02) : 317 - 321
  • [10] Statin use reduces cardiovascular events and all-cause mortality amongst Chinese patients with type 2 diabetes mellitus: a 5-year cohort study
    Fung, Colman Siu Cheung
    Wan, Eric Yuk Fai
    Chan, Anca Ka Chun
    Lam, Cindy Lo Kuen
    BMC CARDIOVASCULAR DISORDERS, 2017, 17